Becozyme

Quick links to important sections

Becozyme

Selected form

Method of action: Vitamins

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Becozyme

Property Description
Active Ingredients Vitamin B Complex (Polyvitamin combination)
Forms Film-coated tablet, Solution for injection
Pharmacological Class Hydro-Soluble Vitamin Preparation / Nutritional Supplement
General Purpose Replenishment of B-vitamin deficiencies
Origin Essential Nutrient (compounds may be synthetic or naturally derived)

Becozyme is a combination product and pharmaceutical preparation classified as a Hydro-Soluble Vitamin Preparation and a Nutritional Supplement. It is fundamentally composed of the Vitamin B Complex, a group of essential nutrients vital for numerous metabolic processes throughout the body.

The product is distinctly recognized for its comprehensive combination of B vitamins, a formulation that has been consistently manufactured under high standards by major pharmaceutical entities. The B vitamins are considered micronutrients essential for normal metabolism and cellular function. Becozyme is available in various dosage forms, most commonly as a film-coated tablet for oral intake, but specific formulations also exist as a solution for injection (ampoules) for parenteral administration, offering alternative delivery methods.


Becozyme's Core Purpose and Function

The general purpose of taking Becozyme is to provide essential metabolic support and replenish deficiencies of the Vitamin B Complex that may arise from inadequate diet or increased bodily demand. This role is clinically recognized for maintaining patient health, particularly in populations with increased metabolic needs.

The B-vitamins act as crucial cofactors and catalysts necessary for the enzymatic reactions that convert consumed food into usable energy. Research highlights the vital role of these vitamins, particularly B6 and B12, in nervous system health and function. By restoring the levels of these essential nutrients, the preparation helps maintain core physiological functions, such as efficient energy metabolism and the promotion of neural integrity. A typical, neutral use scenario involves the supportive management of nutritional deficiency observed in periods of sustained physical stress or poor dietary intake, thereby restoring functional well-being.

Regulatory References

  1. NIH MedlinePlus on B Vitamins

What side effects are possible with Becozyme?

Possible Side Effects and Safety Information

The official safety documentation for this Vitamin B Complex preparation outlines several potential adverse reactions and important safety constraints, categorized by regulatory standards.


Adverse Reactions and System-Organ Classification

The most frequently reported events in regulatory labeling are related to Gastrointestinal Disorders, including abdominal pain, nausea, vomiting, constipation, and transient diarrhea. Nervous System Disorders like headache and dizziness have also been documented. Many systemic reactions are classified as having a Frequency Not Known (Not Possible to Estimate) based on voluntary post-marketing surveillance.

Classification Examples of Documented Reactions
Immune System Disorders Allergic reactions, rash, urticaria, severe hypersensitivity, and Anaphylactic Shock.
Renal and Urinary Disorders Yellow-orange urine discoloration (Chromaturia), which is officially noted as an innocuous physiological finding caused by Vitamin B2 (Riboflavin).

Serious Events and Safety Patterns

The most critical documented safety concern is the potential for Anaphylactic Shock and severe generalized allergic reactions. For parenteral (injection) administration of certain B vitamins, severe events such as Peripheral Vascular Thrombosis have been documented.

Official labeling emphasizes a risk associated with exposure duration: Long-term administration of high doses of Vitamin B6 (Pyridoxine) is associated with the development of severe sensory peripheral neuropathies. High doses of Vitamin B6 may also inhibit breast milk production during lactation, and the product is formally restricted in individuals with known hypersensitivity to the ingredients. Additionally, Pyridoxine can reduce the therapeutic efficacy of Levodopa, as noted in high-level safety restrictions.

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information for Becozyme

Overdose Scope

Property Official Regulatory Statement
Documented Overdose Presentations Chronic, excessive ingestion of Pyridoxine (Vitamin B6) is officially documented to cause peripheral sensory neuropathy. Manifestations include numbness, tingling (paresthesias), ataxia (loss of coordination), and muscle weakness. Acute overdose may present with nausea, vomiting, and diarrhea.
Physiological Systems Affected The official literature documents effects on the Nervous System (sensory neuropathy) and the Gastrointestinal System. Potential liver toxicity is also noted with high-dose Niacin (B3) components.
Exposure-related Factors Toxicity is primarily linked to chronic, high-dose ingestion of B6 supplements. Severe, acute outcomes, such as anaphylactic shock, are documented risks associated with the parenteral (injection) administration of certain B vitamins.
Population-specific Overdose Notes Excessive use of Pyridoxine during pregnancy is officially reported to have resulted in pyridoxine withdrawal seizures in neonates.
When immediate medical help is required Regulatory guidance mandates that individuals must seek medical help right away or call a Poison Control Center immediately upon suspicion of an overdose or development of severe adverse symptoms.

Overdose Classifications (High-Level)

Property Official Regulatory Statement
Severity Classification Overdose risks range from chronic neuropathy to severe, life-threatening events (anaphylaxis) requiring acute care.
Antidote Status and Management The official regulatory literature states that no specific pharmacological antidote is known for Pyridoxine toxicity. Treatment is restricted to symptomatic management and supportive care, beginning with the immediate cessation of all B6 supplements.

Therapeutic Uses of Becozyme

What Becozyme Treats: Main Uses and Benefits

The primary therapeutic role of Becozyme is applied in addressing deficiencies of the Vitamin B Complex, which are often linked to inadequate nutrient status due to poor diet, malabsorption, or increased physiological demand. B vitamins are essential nutrients relevant for symptoms related to systemic imbalance and increased neurological activity.

This preparation is commonly used to help with deficiency-related symptom clusters, including systemic imbalance (chronic fatigue, weakness, malaise), symptoms of increased neurological activity (paresthesia, early peripheral neuropathy signs), and specific inflammatory or irritative states of the mucous membranes and skin (glossitis, cheilosis). The therapeutic use is relevant in conditions involving recurrent or episodic manifestations linked to nutritional deficits, and it is frequently applied during periods of convalescence or conditions marked by increased physiological stress.

“B-vitamin supplementation may be part of symptomatic management in conditions where symptoms may intensify temporarily.”

The product supports symptomatic relief and assists with easing the overall symptom burden associated with these noticeable physiological strains, contributing to easing discomfort during symptomatic periods across multiple domains.


Quick Fact: Use in Neurological Discomfort

Becozyme is relevant for easing symptoms of paresthesia (tingling or numbness) and other sensory disturbances linked to nutritional neuropathy, and may assist with maintaining functional stability.

Regulatory References

  1. NIH MedlinePlus Medical Encyclopedia

Eligibility and Restrictions for Use

The eligibility for using Becozyme is strictly defined by regulatory authorities based on age, specific medical conditions, and physiological states.

Population Status Regulatory Rule
Contraindicated Patients with hypersensitivity to any ingredient, known hypercalcemia or hypercalciuria, or a history of kidney or urinary tract stones must not use this medicine.
Restricted Use is contraindicated in patients with impaired renal function. Specific high-dose formulations are also prohibited in alcoholic patients.

Eligibility is also determined by age. Standard formulations are indicated for adults and adolescents over 11 years of age. Higher-dose or specific Forte versions may set the minimum eligible age at 14 years. Regulatory documents state that safety and effectiveness in children below 11 years are not established.

For pregnant or lactating women, use is generally not recommended or is restricted to medical supervision, as the components are known to be excreted in breast milk. Furthermore, the medicine is only appropriate for Vitamin B12 deficiency caused by dietary issues, and not for deficiencies stemming from malabsorption conditions like atrophic gastritis.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation confirms specific interactions for the components of the Vitamin B Complex, primarily affecting the exposure and efficacy of co-administered medicinal products and influencing administration requirements for injectable formulations.


Documented Pharmacokinetic and Pharmacodynamic Interactions

Exposure-Altering Effects

B Vitamin Component Interacting Medicine Documented Outcome
Folic Acid (B9) Phenytoin (Anticonvulsant) Folic acid increases the metabolic clearance of phenytoin, which formally results in a decrease in phenytoin serum concentrations.
Pyridoxine (B6) Levodopa (Anti-Parkinson Agent) Pyridoxine may cause a decrease in levodopa blood levels, leading to decreased levodopa efficacy.

Efficacy Interference

The B Vitamin components may decrease the activity of certain antibiotics, including Erythromycin, Doxycycline, and Lincomycin. Separately, the antibiotic Chloramphenicol may inhibit the hematologic response to Vitamin B12 therapy, which is an interaction specifically noted in patients with pernicious anemia.


Substance and Procedural Constraints

Substance Interaction: Heavy, chronic alcohol intake over two weeks is documented to induce the malabsorption of Vitamin B12.

Parenteral Incompatibility: The injectable solution is officially declared not physically compatible with alkaline solutions or drugs that are moderately alkaline, such as Aminophylline or Sodium Bicarbonate, which restricts co-mixing.

Diagnostic Constraint: The use of Folic Acid and Vitamin B12 must be avoided prior to blood sampling for megaloblastic anemia diagnosis, as they can mask serum deficits.

Mechanism of Action

Mechanism of Action: Cofactor Restoration

The active B-vitamins operate not as typical pharmacological agents, but as essential cofactor precursors that restore fundamental cellular metabolism. Upon entry, these vitamins are converted to active coenzymes, which then bind to otherwise inactive apoenzymes to form functional holoenzyme complexes.

This mechanism directly affects multiple key pathways. Vitamins B1, B2, and B3 facilitate the generation of Adenosine Triphosphate (ATP) by restoring flux in the Citric Acid Cycle (TCA) and oxidative phosphorylation. Separately, Vitamin B12 and Vitamin B6 contribute to the structural and functional status of the nervous system. B12 acts as a cofactor in reactions critical for myelin sheath formation, while B6 is required for the enzymatic synthesis of key neurotransmitters.

Furthermore, B12 is essential for the recycling of folate, a process vital for supplying the purine and pyrimidine building blocks necessary for DNA and RNA synthesis. This cascade contributes to the proliferation and maturation of cells, including red blood cells. The mechanism is constrained when underlying issues are structural or genetic, or when B12 absorption is prevented by conditions like Intrinsic Factor deficiency.

Dosage and Administration Information

The administration of Becozyme follows strict guidelines specific to its dosage form, which includes both oral and parenteral routes. The injectable solution is approved for administration via intramuscular (IM), intravenous (IV) injection, or IV infusion. Official guidance indicates that oral administration should generally be favored over repeated parenteral use.

Administration Scope

Property Instruction
Route of Administration Oral, Intramuscular (IM), Intravenous (IV), or IV Infusion.
Dosing Schedule Oral: Typically one tablet daily; for specific adult regimens, 2 to 4 tablets per day. Parenteral: 1 to 2 ampoules per day (2 mL). The maximum recommended daily dose must not be exceeded.
Timing in Relation to Meals Taking the oral tablet after a meal is specified to support optimal absorption.
Preparation Requirements Oral tablets must be swallowed whole with water and not crushed or chewed. High concentrations of the IV solution must be diluted with appropriate infusion solutions.
Age-Group Administration Rules Use in children requires strict medical supervision and dose adjustment based on official assessment.
Special Procedural Conditions The intravenous solution must be injected slowly. The treatment duration for certain oral regimens (e.g., functional asthenia) is limited to 4 weeks.

Resulting Procedural Structure

The official use protocol is structured around the chosen route. Oral administration dictates the tablet must be swallowed whole with water, often after a meal. Parenteral administration requires healthcare oversight, with the solution being given via IM, IV, or IV infusion. In all cases, the prescribed once-daily frequency and established dose range must be maintained.

Connection to the overall use protocol (2–4 sentences):

The use protocol defines distinct administration methods based on the formulation, ranging from self-administered oral tablets to medically supervised parenteral injections. This protocol strictly specifies the exact dose limits and necessary procedural steps, such as dilution for intravenous use and a fixed duration for some tablet courses, ensuring standardized administration.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Clinical investigation into B-complex vitamins, the core components of Becozyme, primarily focuses on their role in mitigating deficiencies and supporting neurological and cardiovascular health. Vitamins B1 (Thiamine), B6 (Pyridoxine), and B12 (Cobalamin) are often collectively referred to as neurotropic B vitamins due to their essential function in maintaining nerve health.


Neuropathic Conditions

Research has explored the use of B vitamins in individuals with peripheral neuropathy (nerve damage), which can be associated with conditions like diabetes or alcoholism, or caused by vitamin deficiency itself. Key findings suggest:

  • Combination Studies: Several studies have evaluated the effect of combined B1, B6, and B12 supplementation. In one study involving individuals with alcoholic or diabetic neuropathy, a higher dose of B-complex administered for four weeks was associated with a greater reduction in symptoms and signs compared to a lower dose.
  • Single-Agent Data: While some research with benfotiamine (a derivative of B1) showed a possible short-term benefit on vibration perception threshold, the overall evidence from randomized trials regarding the efficacy of B vitamins alone for treating generalized neuropathy remains limited and inconclusive.

Cognitive and Cardiovascular Health

Research has highlighted the crucial role of B12 and folate (a B vitamin often included in B-complex formulations) in regulating homocysteine levels. Elevated homocysteine is considered an independent risk factor for brain atrophy and dementia risk. Trials, such as VITACOG, have shown that B vitamin supplementation, specifically B12, B6, and folate, can slow the rate of brain shrinkage and potentially improve cognitive performance in older individuals who are at risk or have pre-existing high homocysteine levels.


Hematological Role

B12 and folate are critical for DNA synthesis and hematopoiesis (red blood cell production). A deficiency in either vitamin can lead to megaloblastic anemia (a type of low red blood cell count). B vitamin supplementation is standard treatment for anemia caused by these specific nutritional deficiencies, as both vitamins are necessary to sustain normal cell division and blood health.

Frequently Asked Questions (FAQ)

Common questions about Becozyme (FAQ)

Q: What is the main difference between Becozyme and a regular vitamin B complex supplement?

According to official product information, Becozyme is formally classified and regulated as a medicine or pharmaceutical preparation. This means it is indicated, according to official documents, for the prevention and treatment of documented B-vitamin deficiencies and states of increased nutritional need. Many standard B complex products, by contrast, are regulated as general dietary supplements.

Q: Is Becozyme a multivitamin or only for B vitamins?

Becozyme is fundamentally a Vitamin B Complex product, meaning its core composition is the group of B vitamins. However, certain specific formulations, such as Becozyme C Forte, are documented to also include Vitamin C and sometimes minerals like zinc as active ingredients, making those versions a combination of vitamins beyond the B-group.

Q: Is it true that Becozyme can help with feeling tired or having low energy?

Official information indicates that the B vitamins in the product are essential for converting food into energy through fundamental processes of cellular metabolism. By correcting a documented vitamin B deficiency, the preparation supports the maintenance of efficient metabolic function, which is a factor in supporting the body's energy levels.

Q: What are the most common reasons a healthcare provider would suggest taking Becozyme?

Regulatory documents list the medicine as indicated for the prevention and treatment of B vitamin deficiencies that present with specific clinical signs. These indications include conditions such as Beriberi (a B1 deficiency), Pellagra (a B3 deficiency), and deficiency-related symptoms like Glossitis (inflammation of the tongue) and cheilitis (cracked lips).

Q: Is Becozyme intended for long-term use, or only for a short period?

The intended duration of use depends on the specific regimen; some oral courses are subject to a fixed duration, such as a limit of four weeks. Official safety documentation includes a warning that the long-term administration of excessive doses of the Vitamin B6 component is associated with a risk of developing severe peripheral nerve problems. Exceeding the recommended daily dose over a long period is cautioned against in regulatory warnings.

Q: Does taking Becozyme affect the results of any common blood tests?

Regulatory warnings specify that the use of the Folic Acid and Vitamin B12 components must be avoided prior to blood sampling for the specific diagnosis of megaloblastic anemia. This is because the vitamins can interfere with the results and mask the true level of serum deficits.

Q: Does Becozyme interact negatively with common pain relievers like ibuprofen or paracetamol?

Official documentation lists specific known interactions with agents like Levodopa and Phenytoin. However, no interaction with common over-the-counter pain relievers like ibuprofen or paracetamol is documented in the current regulatory summaries.

Q: Why is folic acid often included in B vitamin formulas like Becozyme?

Folic acid (Vitamin B9) is included because it acts as an essential cofactor critical for DNA synthesis and cell growth throughout the body. Its role is vital for the formation and healthy maturation of cells, particularly in the process of red blood cell production.

Q: Can Becozyme cause any skin-related side effects, like acne or a rash?

Official documentation describes allergic reactions, which include a rash and urticaria (hives), as documented adverse reactions. Furthermore, published medical reports have linked the Vitamin B12 component to rare occurrences of acneiform eruptions in some individuals.

Q: What is the role of Vitamin C when it is combined with B vitamins in a product like Becozyme?

In product formulations that include Vitamin C, the ingredient is included for its documented properties as an antioxidant. According to official information, it is involved in supporting functions like immune system health and contributing to the maintenance of healthy skin and connective tissues.

Q: Are there any warnings about taking Becozyme before having surgery?

Official product labeling for B vitamins does not typically list specific restrictions regarding taking the medicine before general surgery. However, authoritative medical guidance emphasizes informing a doctor about all medicines and supplements being used prior to any procedure.

Q: Why are high-dose B vitamins sometimes used for certain conditions?

High-dose formulations are used for the explicit purpose of curative treatment to rapidly correct marked or severe B vitamin deficiency symptoms, such as those associated with Pellagra or Beriberi. They may also be indicated to meet significantly increased metabolic needs in cases of very poor absorption or high metabolic demand.

Q: What does 'therapeutic dose' mean when referring to a product like Becozyme?

The 'therapeutic dose' refers to the specific, precise quantity of the medicine, such as one tablet daily or a specific volume for injection, that is formally defined in the regulatory documents. This is the amount formally established by health authorities as being intended for correcting a deficiency or providing metabolic support.

Q: Is Becozyme meant to treat vitamin B deficiencies caused by certain diseases?

Official labeling specifies that the medicine should not be used for deficiencies resulting from medical conditions such as atrophic gastritis, malabsorption disorders, or the lack of intrinsic factor. The product is specifically indicated for B vitamin deficiency that is considered to be of food origin (dietary).

Q: Can a person stop taking Becozyme suddenly without any withdrawal effects?

Because the active components are water-soluble B vitamins, they are not generally associated with the physical dependency that causes formal withdrawal symptoms upon cessation. The body typically excretes any unused quantity of these vitamins relatively quickly.

Q: Are there official descriptions of which ingredients in Becozyme are the 'active' ones?

Yes, the official composition documents identify the individual B vitamins, such as Thiamine (B1), Riboflavin (B2), Nicotinamide (B3), and Pyridoxine (B6), as well as any other key components like Vitamin C or Zinc, as the Active Ingredients of the medicine.

Q: How does the body use the different B vitamins provided by Becozyme?

The body utilizes the different B vitamins as coenzymes or cofactors that enable various essential, closely inter-related cellular functions. They are primarily required, according to pharmacological data, for the reactions of energy production from food, the synthesis of DNA, and the production of vital compounds, including certain neurotransmitters.

Q: Is there any published evidence on long-term safety when using Becozyme regularly?

The official safety labeling notes that long-term administration of high doses of the Vitamin B6 component is associated with the development of severe sensory peripheral neuropathies (nerve problems). Exceeding the recommended daily dose over a long period is cautioned against in regulatory documents.

Q: What are the eligibility restrictions for pregnant or breastfeeding individuals using Becozyme?

The use of the medicine during pregnancy is generally not recommended due to a lack of comprehensive safety data, and is restricted to situations where it is clinically indicated. During breastfeeding, the components are known to be excreted into breast milk, and official guidance notes that medical supervision is required to evaluate the continued use of the medicine.

Q: What kind of studies support the use of Becozyme for its intended purpose?

Studies supporting the use of the B-complex components focus on their role in correcting vitamin deficiencies and their potential in supporting neurological and cardiovascular health. Research has specifically examined the effect of combined B vitamins in individuals with peripheral neuropathy and the importance of folate and B12 in regulating homocysteine levels.

Q: What are the common misunderstandings about what Becozyme is supposed to do?

The official documentation clarifies the limits of the medicine's effectiveness. The mechanism of action is constrained and is specifically described as not being effective when the underlying deficiency is due to malabsorption conditions or when the cause is related to structural or genetic issues, indicating that it is not intended for use in all types of deficiency.

How should Becozyme be stored and disposed of?

How to Store and Dispose of Becozyme

The correct storage of Becozyme is essential to protect the stability of the Vitamin B Complex components.


Required Storage Conditions

Becozyme tablets and syrup must generally be stored below 30°C, and specific injection forms may require refrigeration (2° to 8°C). The product must be stored in a dry place and protected from light. It is mandatory that the medicine is not permitted to freeze.

To maintain product integrity, moisture-sensitive forms, such as effervescent tablets, must be kept in a tightly closed container.

Stability and Disposal

For safety, the medicine must be kept out of the sight and reach of children. The product must not be used after the expiration date printed on the package. Additionally, multi-dose injection vials often have an in-use shelf life of 30 days after first opening. Any unused or expired product must be disposed of in accordance with local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Becozyme found in:

A-Z Index: